Dr. Loaiza-Bonilla on Trial of Left- and Right-Sided Colorectal Cancer

Arturo Loaiza-Bonilla, MD
Published: Thursday, Feb 09, 2017



Arturo Loaiza-Bonilla, MD, medical oncologist, specializing in gastrointestinal malignancies, assistant professor of Clinical Medicine at the University of Pennsylvania, discusses a clinical trial focused on the differences between left- and right-sided tumors of colorectal cancer (CRC).

The most recent data that have been presented regarding the sidedness of CRC has been investigated, explains Loaiza-Bonilla. Patients with right-sided CRC, regardless of the chemotherapy they receive, are going to have different survival outcomes compared with patients with left-sided tumors.

When looking at that data it is important to look for specific mutations, genomic alterations, or any molecular underpinning that may explain the reason as to why these patients have less effective outcomes, says Loaiza-Bonilla.

SELECTED
LANGUAGE


Arturo Loaiza-Bonilla, MD, medical oncologist, specializing in gastrointestinal malignancies, assistant professor of Clinical Medicine at the University of Pennsylvania, discusses a clinical trial focused on the differences between left- and right-sided tumors of colorectal cancer (CRC).

The most recent data that have been presented regarding the sidedness of CRC has been investigated, explains Loaiza-Bonilla. Patients with right-sided CRC, regardless of the chemotherapy they receive, are going to have different survival outcomes compared with patients with left-sided tumors.

When looking at that data it is important to look for specific mutations, genomic alterations, or any molecular underpinning that may explain the reason as to why these patients have less effective outcomes, says Loaiza-Bonilla.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Publication Bottom Border
Border Publication
x